JP2005503435A5 - - Google Patents

Download PDF

Info

Publication number
JP2005503435A5
JP2005503435A5 JP2003530673A JP2003530673A JP2005503435A5 JP 2005503435 A5 JP2005503435 A5 JP 2005503435A5 JP 2003530673 A JP2003530673 A JP 2003530673A JP 2003530673 A JP2003530673 A JP 2003530673A JP 2005503435 A5 JP2005503435 A5 JP 2005503435A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
halogen
groups
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003530673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503435A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011921 external-priority patent/WO2003027083A1/en
Publication of JP2005503435A publication Critical patent/JP2005503435A/ja
Publication of JP2005503435A5 publication Critical patent/JP2005503435A5/ja
Pending legal-status Critical Current

Links

JP2003530673A 2001-04-17 2002-04-17 ビシクロ[3.1.0]ヘキサン含有オキサゾリジノン抗生物質及びその誘導体 Pending JP2005503435A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28395601P 2001-04-17 2001-04-17
US36392802P 2002-03-14 2002-03-14
PCT/US2002/011921 WO2003027083A1 (en) 2001-04-17 2002-04-17 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof

Publications (2)

Publication Number Publication Date
JP2005503435A JP2005503435A (ja) 2005-02-03
JP2005503435A5 true JP2005503435A5 (https=) 2006-01-12

Family

ID=30117959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530673A Pending JP2005503435A (ja) 2001-04-17 2002-04-17 ビシクロ[3.1.0]ヘキサン含有オキサゾリジノン抗生物質及びその誘導体

Country Status (9)

Country Link
US (2) US6897230B2 (https=)
EP (1) EP1385834B1 (https=)
JP (1) JP2005503435A (https=)
AT (1) ATE304536T1 (https=)
AU (1) AU2002360238B2 (https=)
CA (1) CA2443410A1 (https=)
DE (1) DE60206154T2 (https=)
ES (1) ES2248633T3 (https=)
WO (1) WO2003027083A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248633T3 (es) * 2001-04-17 2006-03-16 MERCK & CO., INC. Antibioticos oxazolidinona que contienen biciclo (3,1,o)hexano y derivados de los mismos.
US7074801B1 (en) * 2001-04-26 2006-07-11 Eisai Co., Ltd. Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US20080214565A1 (en) * 2003-04-07 2008-09-04 Anita Mehta Oxazolidinone Derivatives as Antimicrobials
WO2004099199A1 (en) * 2003-05-06 2004-11-18 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
DE602004027811D1 (de) * 2003-07-02 2010-08-05 Kyorin Seiyaku Kk Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
CA2529294A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
UA88448C2 (ru) * 2003-07-02 2009-10-26 Мерк Энд Ко., Инк. Оксазолидиноновые антибиотики с замещенной циклопропильной группой и их производные
EP1654259A1 (en) * 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
WO2005005399A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
KR20060095865A (ko) * 2003-10-14 2006-09-04 화이자 프로덕츠 인크. 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
WO2007004032A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidiones containing cyclobutane as antibacterial agents
WO2008126795A1 (ja) * 2007-04-06 2008-10-23 Nippon Soda Co., Ltd. 有害生物防除剤組成物及び有害生物防除方法
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
JP6162704B2 (ja) * 2011-10-11 2017-07-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ オキサゾリジノン誘導体のシラアナログ及びその合成
CN107400126A (zh) * 2016-05-19 2017-11-28 陕西合成药业股份有限公司 新型噁唑烷酮类化合物及其制备方法和在医学上的应用
WO2018170664A1 (en) * 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
CN118164975B (zh) * 2024-05-14 2024-08-09 中国医学科学院医药生物技术研究所 一种季铵盐类噁唑烷酮衍生物及其可药用盐、制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) * 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
ATE146783T1 (de) * 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
EP0673370B1 (en) * 1992-12-08 1998-01-07 PHARMACIA & UPJOHN COMPANY Tropone-substituted phenyloxazolidinone antibacterial agents
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
BR0112826A (pt) * 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Derivados da oxazolidinona como antimicrobianos
ES2248633T3 (es) * 2001-04-17 2006-03-16 MERCK & CO., INC. Antibioticos oxazolidinona que contienen biciclo (3,1,o)hexano y derivados de los mismos.
CA2463794A1 (en) * 2001-11-29 2003-06-12 Merck & Co., Inc. Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
CA2529294A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
DE602004027811D1 (de) * 2003-07-02 2010-08-05 Kyorin Seiyaku Kk Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
WO2005005399A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
EP1654259A1 (en) * 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof

Similar Documents

Publication Publication Date Title
JP2005503435A5 (https=)
RU2481346C2 (ru) Ингибиторы фосфатидилинозитол-3-киназы
AR044990A1 (es) Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos
CA2457054A1 (en) Activator of peroxisome proliferator-activated receptor .delta.
JP2001526269A5 (https=)
JP2013544276A5 (https=)
RU2006112593A (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk
ATE354562T1 (de) Cyclohexylsulfon-derivate als gamma-secretase- inhibitoren
CA2487542A1 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
JP2006507326A5 (https=)
JP2010510233A5 (https=)
JP2013508452A5 (https=)
RU2004119963A (ru) Ингибиторы вич интегразы
RU2006120078A (ru) Производные фосфиновой кислоты, ингибиторы бета-секретазы, предназначенные для лечения болезни альцгеймера
JP2008534453A5 (https=)
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2010536821A5 (https=)
KR920006322A (ko) 벤젠, 피리딘 및 피리미딘 유도체
JP2005529164A5 (https=)
JP2008514650A5 (https=)
JP2009501745A5 (https=)
JP2005526773A5 (https=)
JP2024112835A5 (https=)
RU2014126367A (ru) Производные n-(4-хинолинметил)сульфонамидов и их применение в качестве антигельминтных средств
RU2007125130A (ru) Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1